No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome
Sang Kyun Sohn, Joon Ho Moon, In Hee Lee, Jae Sook Ahn, Hyeoung Joon Kim, Joo Seop Chung, Ho Jin Shin, Sung Woo Park, Won Sik Lee, Sang Min Lee, Hawk Kim, Ho Sup Lee, Yang Soo Kim, Yoon Young Cho, Sung Hwa Bae, Ji Hyun Lee, Sung Hyun Kim, Ik Chan Song, Ji Hyun Kwon, Yoo Jin Lee
Korean J Intern Med. 2018;33(6):1194-1202. Published online 2017 Dec 15 DOI: https://doi.org/10.3904/kjim.2016.426
Citations to this article as recorded by 
Oral Arsenic-Containing Qinghuang Powder: A Potential Drug for Myelodysplastic Syndromes
Jing Ming, Wei-yi Liu, Hai-yan Xiao, Yong-gang Xu, Rou Ma, Xiao-mei Hu
Chinese Journal of Integrative Medicine.2022; 28(8): 762. CrossRef